• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆道黏膜屏障与微生物群

Biliary Mucosal Barrier and Microbiome.

作者信息

Verdier Julien, Luedde Tom, Sellge Gernot

机构信息

Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.

出版信息

Viszeralmedizin. 2015 Jun;31(3):156-61. doi: 10.1159/000431071. Epub 2015 Jun 5.

DOI:10.1159/000431071
PMID:26468308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4569210/
Abstract

BACKGROUND

The biliary system is in continuous contact with the complex microbiota of the intestine. Microbial products have recently been proposed as potential triggers for biliary diseases.

METHODS

The aim of this review is to provide a summary of the current knowledge regarding the role of the biliary and intestinal microbiome in biliary inflammatory diseases.

RESULTS

Previously, it was suggested that the healthy biliary system is a sterile organ, while acute cholangitis and cholecystitis may occur from ascending infections. Although non-inflammatory biliary colonization by certain bacteria such as Salmonella spp. has been already recognized since several decades, human and animal studies indicated only very recently that the gallbladder harbors a complex microbiota also under non-pathologic conditions. Novel findings suggested that - similar to the situation in the intestine - the biliary mucosa features a chemical, mechanical, and immunological barrier, ensuring immunological tolerance against commensals. However, microbial triggers might influence acute and chronic inflammatory disease of the biliary system and the whole liver.

CONCLUSION

Although yet undefined, dysbiosis of the biliary or intestinal microbiota rather than a single microorganism may influence disease progression.

摘要

背景

胆道系统与肠道复杂的微生物群持续接触。微生物产物最近被认为是胆道疾病的潜在触发因素。

方法

本综述的目的是总结当前关于胆道和肠道微生物群在胆道炎性疾病中作用的知识。

结果

以前认为健康的胆道系统是一个无菌器官,而急性胆管炎和胆囊炎可能由上行感染引起。尽管几十年前就已认识到某些细菌(如沙门氏菌属)的非炎性胆道定植,但人类和动物研究直到最近才表明,在非病理条件下胆囊也含有复杂的微生物群。新的研究结果表明,与肠道情况类似,胆道黏膜具有化学、机械和免疫屏障,可确保对共生菌的免疫耐受。然而,微生物触发因素可能会影响胆道系统和整个肝脏的急性和慢性炎症性疾病。

结论

尽管尚未明确,但胆道或肠道微生物群的失调而非单一微生物可能会影响疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c8/4569210/3243cc88bdd6/vim-0031-0156-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c8/4569210/3243cc88bdd6/vim-0031-0156-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3c8/4569210/3243cc88bdd6/vim-0031-0156-g01.jpg

相似文献

1
Biliary Mucosal Barrier and Microbiome.胆道黏膜屏障与微生物群
Viszeralmedizin. 2015 Jun;31(3):156-61. doi: 10.1159/000431071. Epub 2015 Jun 5.
2
Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).微生物对原发性胆汁性肝硬化(PBC)和原发性硬化性胆管炎(PSC)发病机制的影响。
Int J Mol Sci. 2016 Nov 9;17(11):1864. doi: 10.3390/ijms17111864.
3
Intestinal microbiota and biliary system diseases.肠道微生物群与胆道系统疾病。
Front Cell Infect Microbiol. 2024 Mar 15;14:1362933. doi: 10.3389/fcimb.2024.1362933. eCollection 2024.
4
The gut microbial influence on cholestatic liver disease.肠道微生物对胆汁淤积性肝病的影响。
Liver Int. 2019 Jul;39(7):1186-1196. doi: 10.1111/liv.14153. Epub 2019 Jun 17.
5
[Radiologic diagnosis of the gallbladder and bile ducts - part 2 : Acute and chronic cholecystitis, primary sclerosing cholangitis (PSC), benign and malignant masses of the biliary system].[胆囊和胆管的放射学诊断 - 第2部分:急性和慢性胆囊炎、原发性硬化性胆管炎(PSC)、胆道系统的良性和恶性肿块]
Radiologe. 2018 Dec;58(12):1099-1114. doi: 10.1007/s00117-018-0463-8.
6
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.胆汁酸与自身免疫性胆汁淤积性肝病的肠道微生物群。
Autoimmun Rev. 2017 Sep;16(9):885-896. doi: 10.1016/j.autrev.2017.07.002. Epub 2017 Jul 8.
7
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
8
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?肠道菌群失调在肝脏疾病中的作用:我们目前了解到了什么?
Diseases. 2019 Nov 12;7(4):58. doi: 10.3390/diseases7040058.
9
The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile.人类胆囊微生物组与生理状态和胆汁代谢特征有关。
Microbiome. 2019 Jul 4;7(1):100. doi: 10.1186/s40168-019-0712-8.
10
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.原发性硬化性胆管炎小鼠模型中肠道菌群失调通过 NLRP3 增强肝脏疾病进展。
Gut. 2019 Aug;68(8):1477-1492. doi: 10.1136/gutjnl-2018-316670. Epub 2019 Mar 14.

引用本文的文献

1
Liver immunology: Biological role and clinical significance.肝脏免疫学:生物学作用及临床意义。
World J Hepatol. 2025 Jul 27;17(7):107541. doi: 10.4254/wjh.v17.i7.107541.
2
Biliary Microbial Community and Metabolic Potential in Patients with Multiple Common Bile Duct Stones.多发性胆总管结石患者的胆道微生物群落与代谢潜能
Clin Exp Gastroenterol. 2025 May 7;18:67-78. doi: 10.2147/CEG.S512350. eCollection 2025.
3
Significant Microbial Pathogenesis Perspective of Biliary Diseases.胆道疾病的重要微生物发病机制视角

本文引用的文献

1
Liver inflammation abrogates immunological tolerance induced by Kupffer cells.肝脏炎症会破坏枯否细胞诱导的免疫耐受。
Hepatology. 2015 Jul;62(1):279-91. doi: 10.1002/hep.27793. Epub 2015 Apr 22.
2
The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.原发性硬化性胆管炎(PSC)患者的黏膜相关微生物群的特征是未培养的梭菌目II多样性低且丰度低。
J Crohns Colitis. 2015 Apr;9(4):342-8. doi: 10.1093/ecco-jcc/jju023. Epub 2014 Dec 28.
3
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
Infect Disord Drug Targets. 2025;25(4):e18715265302000. doi: 10.2174/0118715265302000240913092037.
4
Millimeter-scale soft capsules for sampling liquids in fluid-filled confined spaces.毫米级软胶囊,用于在充满液体的封闭空间中取样液体。
Sci Adv. 2024 Aug 30;10(35):eadp2758. doi: 10.1126/sciadv.adp2758. Epub 2024 Aug 28.
5
Updates on Antibiotic Regimens in Acute Cholecystitis.急性胆囊炎抗生素治疗方案的最新进展。
Medicina (Kaunas). 2024 Jun 25;60(7):1040. doi: 10.3390/medicina60071040.
6
Characterization of biliary and duodenal microbiota in patients with primary and recurrent choledocholithiasis.原发性和复发性胆总管结石患者胆汁和十二指肠微生物群的特征分析
Health Inf Sci Syst. 2024 Apr 4;12(1):29. doi: 10.1007/s13755-023-00267-2. eCollection 2024 Dec.
7
The gut microbiome predicts response to UDCA/CDCA treatment in gallstone patients: comparison of responders and non-responders.肠道微生物组预测胆石病患者对 UDCA/CDCA 治疗的反应:应答者与无应答者的比较。
Sci Rep. 2024 Jan 30;14(1):2534. doi: 10.1038/s41598-024-53173-2.
8
Profiles of biliary microbiota in biliary obstruction patients with infection.胆道梗阻合并感染患者的胆道微生物特征。
Front Cell Infect Microbiol. 2023 Dec 18;13:1281745. doi: 10.3389/fcimb.2023.1281745. eCollection 2023.
9
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis.严重急性胆管炎患者血浆和胆汁中微生物群衍生的促凋亡肽corisin水平升高。
Gut Pathog. 2023 Nov 30;15(1):59. doi: 10.1186/s13099-023-00587-4.
10
Getting off tract: contributions of intraorgan microbiota to cancer in extraintestinal organs.脱离轨道:肠道内微生物群落在肠道外器官癌症中的作用。
Gut. 2023 Dec 7;73(1):175-185. doi: 10.1136/gutjnl-2022-328834.
微生物群与肠-肝轴:肝硬化中的细菌易位、炎症和感染
World J Gastroenterol. 2014 Dec 7;20(45):16795-810. doi: 10.3748/wjg.v20.i45.16795.
4
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.精准微生物群重建可恢复胆汁酸介导的对艰难梭菌的抗性。
Nature. 2015 Jan 8;517(7533):205-8. doi: 10.1038/nature13828. Epub 2014 Oct 22.
5
Characterization of the bile and gall bladder microbiota of healthy pigs.健康猪胆汁和胆囊微生物群的特征分析。
Microbiologyopen. 2014 Dec;3(6):937-49. doi: 10.1002/mbo3.218. Epub 2014 Oct 21.
6
Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness.肠道上皮的快速岩藻糖基化在疾病状态下维持宿主与共生菌的共生关系。
Nature. 2014 Oct 30;514(7524):638-41. doi: 10.1038/nature13823. Epub 2014 Oct 1.
7
Regional specialization within the intestinal immune system.肠道免疫系统的区域专业化。
Nat Rev Immunol. 2014 Oct;14(10):667-85. doi: 10.1038/nri3738. Epub 2014 Sep 19.
8
The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.肠道微生物组在肝硬化和肝细胞癌的发生和发展中的作用。
Gut Microbes. 2014 Jul 1;5(4):441-5. doi: 10.4161/gmic.29599. Epub 2014 Jul 9.
9
Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.系统评价:炎症性肠病患者肝胆系统表现的流行病学。
Aliment Pharmacol Ther. 2014 Jul;40(1):3-15. doi: 10.1111/apt.12794. Epub 2014 May 11.
10
The treatment-naive microbiome in new-onset Crohn's disease.初发克罗恩病的治疗初治微生物组。
Cell Host Microbe. 2014 Mar 12;15(3):382-392. doi: 10.1016/j.chom.2014.02.005.